- Home
- HCP vs ALKS Comparison
HCP vs ALKS Comparison
Compare HCP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCP
- ALKS
- Stock Information
- Founded
- HCP 2012
- ALKS 1987
- Country
- HCP United States
- ALKS Ireland
- Employees
- HCP N/A
- ALKS N/A
- Industry
- HCP EDP Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- HCP Technology
- ALKS Health Care
- Exchange
- HCP Nasdaq
- ALKS Nasdaq
- Market Cap
- HCP 7.0B
- ALKS 5.7B
- IPO Year
- HCP 2021
- ALKS 1991
- Fundamental
- Price
- HCP $34.50
- ALKS $35.32
- Analyst Decision
- HCP Hold
- ALKS Buy
- Analyst Count
- HCP 14
- ALKS 12
- Target Price
- HCP $32.80
- ALKS $37.25
- AVG Volume (30 Days)
- HCP 3.6M
- ALKS 1.9M
- Earning Date
- HCP 03-06-2025
- ALKS 02-12-2025
- Dividend Yield
- HCP N/A
- ALKS N/A
- EPS Growth
- HCP N/A
- ALKS 3.47
- EPS
- HCP N/A
- ALKS 2.17
- Revenue
- HCP $654,890,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- HCP $17.07
- ALKS N/A
- Revenue Next Year
- HCP $12.69
- ALKS $4.67
- P/E Ratio
- HCP N/A
- ALKS $16.05
- Revenue Growth
- HCP 16.29
- ALKS N/A
- 52 Week Low
- HCP $21.50
- ALKS $22.90
- 52 Week High
- HCP $34.54
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- HCP 64.50
- ALKS 71.72
- Support Level
- HCP $33.95
- ALKS $31.01
- Resistance Level
- HCP $34.53
- ALKS $36.45
- Average True Range (ATR)
- HCP 0.19
- ALKS 1.05
- MACD
- HCP 0.03
- ALKS 0.32
- Stochastic Oscillator
- HCP 93.75
- ALKS 81.57
About HCP HashiCorp Inc.
HashiCorp Inc is engaged in solving the infrastructure challenges of cloud adoption by enabling an operating model that unlocks the full potential of modern public and private clouds. Its cloud operating model provides consistent workflows and a standardized approach to automate the processes involved in delivering applications in the cloud: infrastructure provisioning, security, networking, and application deployment. Its main commercial products are Terraform, Vault, Consul, and Nomad.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.